These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24773358)

  • 1. Treatment noncompliance in randomized experiments: statistical approaches and design issues.
    Sagarin BJ; West SG; Ratnikov A; Homan WK; Ritchie TD; Hansen EJ
    Psychol Methods; 2014 Sep; 19(3):317-33. PubMed ID: 24773358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling compliers and noncompliers for instrumental variable analysis with covariates: A weighting approach.
    Choi BY
    PLoS One; 2023; 18(6):e0283223. PubMed ID: 37319247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complier Average Causal Effect Parameter for Multiarmed RCTs.
    Schochet PZ
    Eval Rev; 2020 Oct; 44(5-6):410-436. PubMed ID: 33375826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
    Shan N; Xu PF
    Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.
    Loeys T; Goetghebeur E
    Biometrics; 2003 Mar; 59(1):100-5. PubMed ID: 12762446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian hierarchical model estimating CACE in meta-analysis of randomized clinical trials with noncompliance.
    Zhou J; Hodges JS; Suri MFK; Chu H
    Biometrics; 2019 Sep; 75(3):978-987. PubMed ID: 30690716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal.
    Guo L; Qian Y; Xie H
    Stat Med; 2022 Jun; 41(13):2448-2465. PubMed ID: 35274333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Complier Average Causal Effect in a Meta-Analysis of Randomized Clinical Trials With Binary Outcomes Accounting for Noncompliance: A Generalized Linear Latent and Mixed Model Approach.
    Zhou T; Zhou J; Hodges JS; Lin L; Chen Y; Cole SR; Chu H
    Am J Epidemiol; 2022 Jan; 191(1):220-229. PubMed ID: 34564720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustment for compliance behavior in trials of epidural analgesia in labor using instrumental variable meta-analysis.
    Bannister-Tyrrell M; Miladinovic B; Roberts CL; Ford JB
    J Clin Epidemiol; 2015 May; 68(5):525-33. PubMed ID: 25592169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to spillover effects in cluster randomized trials with noncompliance.
    Keele L; Kang H
    Clin Trials; 2022 Aug; 19(4):375-379. PubMed ID: 35510562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.